From April 18, 2024 to June 30, 2024, the company has repurchased 5,436,100 shares, representing 0.93% for CNY 13.01 million. With this, the company has completed the repurchase of 5,436,100 shares, representing 0.93% for CNY 13.01 million under the buyback announced on April 19, 2024.
Qinghai Spring Medicinal Resources Technology Co., Ltd.
Equities
600381
CNE0000017W0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 CNY | -2.62% |
|
+10.40% | -71.15% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-71.15% | 185M | |
+18.96% | 5.36B | |
-35.85% | 3.42B | |
-1.93% | 2.98B | |
-25.03% | 2.6B | |
-11.29% | 2.27B | |
+43.83% | 1.88B | |
+42.68% | 1.44B | |
+40.95% | 1.4B | |
-15.74% | 1.38B |
- Stock Market
- Equities
- 600381 Stock
- News Qinghai Spring Medicinal Resources Technology Co., Ltd.
- Tranche Update on Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback Plan announced on April 19, 2024.